H2O2-responsive molecularly engineered polymer nanoparticles as ischemia/reperfusion-targeted nanotherapeutic agents.
H2O2-responsive molecularly engineered polymer nanoparticles as ischemia/reperfusion-targeted nanotherapeutic agents.
复制标题
DOI:
10.1038/srep02233
复制
发表时间:
2013
影响因子:
4.6
通讯作者:
Kang, Peter M.
中科院分区:
文献类型:
--
作者:
Lee, Dongwon;Bae, Soochan;Hong, Donghyun;Lim, Hyungsuk;Yoon, Joo Heung;Hwang, On;Park, Seunggyu;Ke, Qingen;Khang, Gilson;Kang, Peter M.
The main culprit in the pathogenesis of ischemia/reperfusion (I/R) injury is the overproduction of reactive oxygen species (ROS). Hydrogen peroxide (H2O2), the most abundant form of ROS produced during I/R, causes inflammation, apoptosis and subsequent tissue damages. Here, we report H2O2-responsive antioxidant nanoparticles formulated from copolyoxalate containing vanillyl alcohol (VA) (PVAX) as a novel I/R-targeted nanotherapeutic agent. PVAX was designed to incorporate VA and H2O2-responsive peroxalate ester linkages covalently in its backbone. PVAX nanoparticles therefore degrade and release VA, which is able to reduce the generation of ROS, and exert anti-inflammatory and anti-apoptotic activity. In hind-limb I/R and liver I/R models in mice, PVAX nanoparticles specifically reacted with overproduced H2O2 and exerted highly potent anti-inflammatory and anti-apoptotic activities that reduced cellular damages. Therefore, PVAX nanoparticles have tremendous potential as nanotherapeutic agents for I/R injury and H2O2-associated diseases.
登录
查看更多内容
影响因子:
15.9
作者:
GOTTLIEB, RA;BURLESON, KO;ENGLER, RL
通讯作者:
ENGLER, RL
DOI:
10.1016/s0967-2109(02)00070-4
发表时间:
2002-12-01
期刊:
CARDIOVASCULAR SURGERY
影响因子:
--
作者:
Blaisdell, FW
通讯作者:
Blaisdell, FW
影响因子:
6.7
作者:
Lee, Ji Yun;Jang, Young Woon;Kim, Chang Jong
通讯作者:
Kim, Chang Jong
影响因子:
15
作者:
Chang, MCY;Pralle, A;Chang, CJ
通讯作者:
Chang, CJ
影响因子:
7.4
作者:
Sawyer, RT;Dobis, DR;Day, BJ
通讯作者:
Day, BJ